UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 49.

Zuellig, R A; Cavallari, G; Gerber, P; Tschopp, O; Spinas, G A; Moritz, W; Lehmann, R (2017). Improved physiological properties of gravity-enforced reassembled rat and human pancreatic pseudo-islets. Journal of Tissue Engineering and Regenerative Medicine, 11(1):109-120.

ORIGIN, Trial Investigators; Punthakee, Z; Gerstein, H C; Spinas, G A; et al (2016). Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE). Diabetes Care, 39(5):709-716.

Hochuli, M; Baumgartner, M R; Spinas, G A (2015). Angeborene Stoffwechselkrankheiten in der Erwachsenenmedizin. Swiss Medical Forum, 5051(15):1176-1178.

Gerber, P A; Zimmermann, D; Spinas, G A (2013). Diabetes melitus Typ 1 - neue Entwicklungen in der intensivierten Insulintherapie. Swiss Medical Forum, 13(23):443-447.

Truninger, R; Uthoff, H; Capraro, J; Frauchiger, B; Spinas, G A; Wiesli, P (2013). Glucose control during a driving training in patients with type 1 and type 2 diabetes mellitus - a randomised, controlled trial. Experimental and Clinical Endocrinology & Diabetes, 121(7):420-424.

Spinas, G A (2013). ORIGIN: eine Meilenstein- oder Puzzle-Studie. Swiss Medical Forum, 13:31-32.

Gerber, P A; Locher, R; Schmid, B; Spinas, G A; Lehmann, R (2013). Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases (NMCD), 23(2):102-108.

Gerber, P A; Spinas, G A; Berneis, K (2012). Small dense low-density lipoprotein particles: priority as a treatment target in type 2 diabetes? Diabetes Management, 2(1):65-74.

Faulenbach, M; Uthoff, H; Schwegler, K; Spinas, G A; Schmid, C; Wiesli, P (2012). Effect of psychological stress on glucose control in patients with Type 2 diabetes. Diabetic Medicine, 29(1):128-131.

Mikhailidis, D P; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, A; Athyros, V; de Graaf, J; März, W; Parhofer, K G; Rini, G B; Spinas, G A; Tomkin, G H; Tselepis, A D; Wierzbicki, A S; Winkler, K; Florentin, M; Liberopoulos, E (2011). "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Current Vascular Pharmacology, 9(5):533-571.

Mikhailidis, D P; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, A; Athyros, V; de Graaf, J; März, W; Parhofer, K G; Rini, G B; Spinas, G A; Tomkin, G H; Tselepis, A D; Wierzbicki, A S; Winkler, K; Florentin, M; Liberopoulos, E (2011). "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Executive summary. Current Vascular Pharmacology, 9(5):531-532.

Wiesli, P; Uthoff, H; Perren, A; Pfammatter, T; Zwimpfer, C; Seiler, H; Kindhauser, R; Spinas, G A; Schmid, C (2011). Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas? Pancreas, 40(7):995-999.

Esterházy, D; Stützer, I; Wang, H; Rechsteiner, M P; Beauchamp, J; Döbeli, H; Hilpert, H; Matile, H; Prummer, M; Schmidt, A; Lieske, N; Boehm, B; Marselli, L; Bosco, D; Kerr-Conte, J; Aebersold, R; Spinas, G A; Moch, H; Migliorini, C; Stoffel, M (2011). Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass. Cell Metabolism, 14(3):365-377.

Aeberli, I; Gerber, P A; Hochuli, M; Kohler, S; Haile, S R; Gouni-Berthold, I; Berthold, H K; Spinas, G A; Berneis, K (2011). Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. American Journal of Clinical Nutrition, 94(2):479-485.

Imthurn, B (2011). Ovar. In: Spinas, G A; Fischli, S. Endokrinologie und Stoffwechsel kompakt. Stuttgart : Georg Thieme Verlag, 85-97.

Xu, L; Spinas, G A; Niessen, M (2011). Pro- or Anti-inflammatory Properties of the Adipokine Dipeptidyl Peptidase-4? Gastroenterology, 141(6):e17.

Berneis, K; Rizzo, M; Evans, J; Rini, G B; Spinas, G A; Goedecke, J H (2010). Interleukin-18 levels are associated with low-density lipoproteins size. European Journal of Clinical Investigation, 40(1):54-55.

Buzzi, F; Xu, L; Zuellig, R A; Boller, S B; Spinas, G A; Hynx, D; Chang, Z; Yang, Z; Hemmings, B A; Tschopp, O; Niessen, M (2010). Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Molecular and Cellular Biology, 30(3):601-612.

Xu, L; Spinas, G A; Niessen, M (2010). ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et métabolisme, 42(9):643-651.

Goedecke, J H; Utzschneider, K; Faulenbach, M V; Rizzo, M; Berneis, K; Spinas, G A; Dave, J A; Levitt, N S; Lambert, E V; Olsson, T; Kahn, S E (2010). Ethnic differences in serum lipoproteins and their determinants in South African women. Metabolism: Clinical and Experimental, 59(9):1341-1350.

Berneis, K; Rizzo, M; Berthold, H K; Spinas, G A; Krone, W; Gouni-Berthold, I (2010). Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial. European Heart Journal, 31(13):1633-1639.

Rizzo, M; Spinas, G A; Rini, G B; Berneis, K (2010). Is diabetes the cost to pay for a greater cardiovascular prevention? International Journal of Cardiology, 144(2):309-310.

Rizzo, M; Pernice, V; Frasheri, A; Di Lorenzo, G; Rini, G B; Spinas, G A; Berneis, K (2009). Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clinical Endocrinology, 70(6):870-875.

Rizzo, M; Rini, G B; Spinas, G A; Berneis, K (2009). The effects of ezetimibe on LDL-cholesterol: Quantitative or qualitative changes? Atherosclerosis, 204(2):330-333.

Rizzo, M; Berneis, K; Hersberger, M; Pepe, I; Di Fede, G; Rini, G B; Spinas, G A; Carmina, E (2009). Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Human Reproduction, 24(9):2286-2292.

Berneis, K; Rizzo, M; Hersberger, M; Rini, G B; Di Fede, G; Pepe, I; Spinas, G A; Carmina, E (2009). Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. International Journal of Clinical Practice, 63(1):56-62.

Rizzo, M; Spinas, G A; Cesur, M; Ozbalkan, Z; Rini, G B; Berneis, K (2009). Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. Atherosclerosis, 207(2):502-506.

Aeberli, I; Spinas, G A; Lehmann, R; l'Allemand, D; Molinari, L; Zimmermann, M B (2009). Diet determines features of the metabolic syndrome in 6- to 14-year-old children. International Journal for Vitamin and Nutrition Research, 79(1):14-23.

Brändle, M; Erny-Albrecht, K M; Goodall, G; Spinas, G A; Streit, P; Valentine, W J (2009). Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland. International Journal of Clinical Pharmacology and Therapeutics, 47(8):501-515.

Rizzo, M; Rizvi, A A; Spinas, G A; Rini, G B; Berneis, K (2009). Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opinion on Investigational Drugs, 18(10):1495-1503.

Rizzo, M; Berneis, K; Spinas, G A; Rini, G B; Carmina, E (2009). Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertility and Sterility, 91(4 Supp):1563-1567.

Philippe, J; Brändle, M; Carrel, J; Diem, P; Keller, U; Kuntschen, F; Ruiz, J; Stahl, M; Weissenberger, B; Spinas, G A (2009). Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2 Diabetes-mellitus. Swiss Medical Weekly, 9(3):50-55.

Rizzo, M; Berneis, K; Spinas, G A; Rini, G B; Kapur, N K (2009). Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance? International Journal of Clinical Practice, 63(3):478-485.

Berneis, K; Rizzo, M; Spinas, G A; Di Lorenzo, G; Di Fede, G; Pepe, I; Pernice, V; Rini, G B (2009). The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis. Clinica Chimica Acta, 406(1-2):36-40.

Aeberli, I; Beljean, N; Lehmann, R; L'Allemand, D; Spinas, G A; Zimmermann, M B (2008). The increase of fatty acid-binding protein aP2 in overweight and obese children: interactions with dietary fat and impact on measures of subclinical inflammation. International Journal of Obesity, 32(10):1513-1520.

Krayenbuehl, P A; Wiesli, P; Schmid, C; Lehmann, R; Spinas, G A; Berneis, K (2008). Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size. Swiss Medical Weekly, 138(19-20):275-280.

Gerber, P A; Pavlicek, V; Demartines, N; Zuellig, R; Pfammatter, T; Wüthrich, R; Weber, M; Spinas, G A; Lehmann, R (2008). Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up. Diabetologia, 51(1):110-119.

Rizzo, M; Berneis, K; Altinova, A E; Toruner, F B; Akturk, M; Ayvaz, G; Rini, G B; Spinas, G A; Arslan, M (2008). Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabetic Medicine, 25(12):1406-1411.

Lehmann, R; Spinas, G A; Moritz, W; Weber, M (2008). Has time come for new goals in human islet transplantation. American Journal of Transplantation, 8(6):1096-1100.

Stallmach, T; Klöppel, G; Roth, J; Spinas, G A (2008). Stoffwechselerkrankungen. In: Böcker, W; Denk, H; Heitz, P U; Moch, H. Pathologie. München: Urban und Fischer, 1123-1147.

Rizzo, M; Christ, E R; Rini, G B; Spinas, G A; Berneis, K (2008). The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Expert Opinion on Pharmacotherapy, 9(13):2295-2303.

Schwegler, B; Stumpe, K D M; Weishaupt, D; Strobel, K; Spinas, G A; von Schulthess, G K; Hodler, J; Böni, Thomas; Donath, M Y (2008). Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. Journal of Internal Medicine, 263(1):99-106.

Lehmann, R; Zuellig, R A; Kugelmeier, P; Baenninger, P B; Moritz, W; Perren, A; Clavien, P A; Weber, M; Spinas, G A (2007). Superiority of small islets in human islet transplantation. Diabetes, 56(3):594-603.

Borter, E; Niessen, M; Zuellig, R; Spinas, G A; Spielmann, P; Camenisch, G; Wenger, R H (2007). Glucose-stimulated insulin production in mice deficient for the PAS kinase PASKIN. Diabetes, 56(1):113-117.

Niessen, M; Jaschinski, F; Item, F; McNamara, M P; Spinas, G A; Trüb, T (2007). Insulin receptor substrates 1 and 2 but not Shc can activate the insulin receptor independent of insulin and induce proliferation in CHO-IR cells. Experimental Cell Research, 313(4):805-815.

Wiesli, P; Schmid, C; Kerwer, O; Nigg-Koch, C; Klaghofer, R; Seifert, Burkhardt; Spinas, G A; Schwegler, K (2005). Acute psychological stress affects glucose concentrations in patients with type 1 diabetes following food intake but not in the fasting state. Diabetes Care, 28(8):1910-1915.

Mohanty, S; Spinas, G A; Maedler, K; Zuellig, R A; Lehmann, R; Donath, M Y; Trüb, T; Niessen, M (2005). Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Experimental Cell Research, 303(1):68-78.

Amacker-Françoys, I; Mohanty, S; Niessen, M; Spinas, G A; Trüb, T (2005). The metabolisable hexoses D-glucose and D-mannose enhance the expression of IRS-2 but not of IRS-1 in pancreatic beta-cells. Experimental and Clinical Endocrinology & Diabetes, 113(8):423-429.

Vorschläge einer interdisziplinären Arbeitsgruppe zur Diagnostik und Therapie des metabolischen Syndroms. Edited by: Lehmann, Roger; Gutzwiller, Felix; Battegay, Edouard; Burnier, M; Carrel, J; Diem, P; Gaillard, R; Greminger, P; Lareida, J; Muggli, F; Noll, G; Philipp, J; Riesen, Walter F; Spinas, G A (2003). Basel: EMH.

This list was generated on Mon Jul 24 06:26:47 2017 CEST.